Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Weighted Average): 2012-2025

Historic Shares Outstanding (Weighted Average) for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $74.6 million.

  • CorMedix's Shares Outstanding (Weighted Average) rose 33.64% to $74.6 million in Q3 2025 from the same period last year, while for Jun 2025 it was $67.8 million, marking a year-over-year increase of 23.41%. This contributed to the annual value of $60.7 million for FY2024, which is 10.70% up from last year.
  • CorMedix's Shares Outstanding (Weighted Average) amounted to $74.6 million in Q3 2025, which was up 10.06% from $67.8 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Shares Outstanding (Weighted Average) registered a high of $74.6 million during Q3 2025, and its lowest value of $38.0 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $55.4 million (2024), whereas its average is $57.9 million.
  • Data for CorMedix's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 45.65% (in 2021) over the last 5 years.
  • CorMedix's Shares Outstanding (Weighted Average) (Quarterly) stood at $38.7 million in 2021, then climbed by 14.90% to $44.5 million in 2022, then skyrocketed by 33.31% to $54.8 million in 2023, then increased by 1.92% to $60.7 million in 2024, then skyrocketed by 33.64% to $74.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $74.6 million in Q3 2025, compared to $67.8 million in Q2 2025 and $65.2 million in Q1 2025.